These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2139669)

  • 1. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
    Arend WP; Welgus HG; Thompson RC; Eisenberg SP
    J Clin Invest; 1990 May; 85(5):1694-7. PubMed ID: 2139669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants.
    Nicod LP; el Habre F; Dayer JM
    Cytokine; 1992 Jan; 4(1):29-35. PubMed ID: 1535518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.
    Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL
    Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
    Arend WP; Joslin FG; Thompson RC; Hannum CH
    J Immunol; 1989 Sep; 143(6):1851-8. PubMed ID: 2528582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant interleukin-1 receptor antagonist inhibits lymphocyte blastogenesis induced by concanavalin A. Restorative effect of hrIL-1.
    Conti P; Reale M; Panara MR; Barbacane RC; Bongrazio M; Dempsey RA
    FEBS Lett; 1991 Jul; 286(1-2):137-41. PubMed ID: 1830851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.
    Dayer JM; de Rochemonteix B; Burrus B; Demczuk S; Dinarello CA
    J Clin Invest; 1986 Feb; 77(2):645-8. PubMed ID: 3003163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids.
    Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C
    J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
    Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    Tocci MJ; Hutchinson NI; Cameron PM; Kirk KE; Norman DJ; Chin J; Rupp EA; Limjuco GA; Bonilla-Argudo VM; Schmidt JA
    J Immunol; 1987 Feb; 138(4):1109-14. PubMed ID: 2949012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
    Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple biological activities of human recombinant interleukin 1.
    Dinarello CA; Cannon JG; Mier JW; Bernheim HA; LoPreste G; Lynn DL; Love RN; Webb AC; Auron PE; Reuben RC
    J Clin Invest; 1986 Jun; 77(6):1734-9. PubMed ID: 3519678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells.
    Arend WP; Coll BP
    Cytokine; 1991 Sep; 3(5):407-13. PubMed ID: 1836395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F; Dayer JM; Modoux C; Hyka N; Burger D
    Cytokine; 2001 Jun; 14(5):272-82. PubMed ID: 11444907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of human chondrocyte metabolism by recombinant human interferon.
    Henrotin YE; Zheng SX; Labasse AH; Deby GP; Crielaard JM; Reginster JY
    Osteoarthritis Cartilage; 2000 Nov; 8(6):474-82. PubMed ID: 11069732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory effects of a synthetic monosaccharide.
    Chang DM
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):437-50. PubMed ID: 8576539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
    Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
    Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
    Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
    J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.